InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
bell345 Free
06/20/17 10:48 PM
profile icon
BettingAngles Free
02/17/14 7:17 PM
profile icon
BettingAngles Free
02/17/14 7:14 PM
profile icon
bell345 Free
10/20/13 9:30 PM
profile icon
wiedsche Free
10/20/13 5:44 AM
profile icon
bell345 Free
10/19/13 7:38 PM
profile icon
996 Free
10/19/13 6:30 AM
profile icon
996 Free
10/19/13 6:30 AM
profile icon
kranthikumar Free
06/07/13 10:28 AM
profile icon
Value_Investor Free
03/25/13 7:06 PM
profile icon
markflfl Free
10/06/12 12:01 PM
profile icon
Hedgebunny Terminated
09/28/12 4:49 PM
profile icon
bell345 Free
09/15/12 6:42 AM
profile icon
Value_Investor Free
09/14/12 4:33 PM
profile icon
Value_Investor Free
09/14/12 9:51 AM
profile icon
markflfl Free
09/14/12 6:41 AM
profile icon
VinnyFuccahucci Free
09/12/12 12:25 PM
profile icon
Renee PremiumMember
09/12/12 8:43 AM
profile icon
Brico Free
09/11/12 12:28 PM
profile icon
Value_Investor Free
09/08/12 1:42 PM
profile icon
markflfl Free
09/07/12 8:16 PM
profile icon
VinnyFuccahucci Free
09/07/12 12:51 PM
profile icon
Value_Investor Free
09/07/12 12:29 PM
profile icon
Value_Investor Free
09/07/12 12:27 PM
profile icon
Value_Investor Free
09/07/12 11:25 AM
profile icon
Value_Investor Free
09/06/12 4:12 PM
profile icon
Value_Investor Free
09/06/12 1:31 PM
profile icon
Value_Investor Free
09/06/12 12:03 PM
profile icon
Value_Investor Free
09/06/12 11:04 AM
profile icon
Value_Investor Free
09/05/12 4:29 PM
profile icon
Value_Investor Free
09/05/12 3:32 PM
profile icon
Value_Investor Free
09/05/12 3:21 PM
profile icon
markflfl Free
09/05/12 3:18 PM
profile icon
Value_Investor Free
09/04/12 5:07 PM
profile icon
markflfl Free
09/04/12 4:10 PM
profile icon
Value_Investor Free
09/04/12 1:22 PM
profile icon
Value_Investor Free
09/02/12 2:19 PM

Jiangbo Pharmaceuticals, Inc.(fka JGBO) RSS Feed

Followers
61
Posters
280
Posts (Today)
0
Posts (Total)
8313
Created
08/20/01
Type
Free
Moderators


Outstanding Shares:  13,692,179 shares.

Floating Shares: 7,370,000 Shares.

Shorting Shares:  110,181 Shares On 04/30/2012.

Insiders Ownership:  40.91%.

Institution Ownership:  3,247,785 shares or 23.72%.
(Pope alone owns 2,234,088 shares or 16.32% of OS)


Shareholder's Equity:  $184,707,495.

Book Value:  $13.49 Per Share.


Total Cash:  $146,930,000.

Cash Value:  $10.73 Per Share.


Revenue:  $98,510,000.

Revenue Per Share: $7.88.

Gross Profit:  $71,350,000.

Diluted EPS:  $2.56.

 
Operating Cash Flow:  $47,780,000.

Leveled Free Cash Flow:  $24,310,000.


52-Week Range Before Halt:  $3.01 ~ $10.98.


 52-Week Range After Halt: $0.0811 ~ $0.8.


 

 
Middle Section, Longmao Street Area A
Laiyang Waixiangxing Industrial Park
Laiyang City, Yantai, 265200 China
 
 

Company Profile

Company : Jiangbo Pharmaceuticals, Inc.
Industry : Biotechnology
Headquarters : Laiyang Waixiangxing Industrial Park
Ticker Symbol : JGBO
Exchange : NASDAQ
 
Jiangbo Pharmaceuticals, Inc. (JGBO) is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong province. Jiangbo is a major pharmaceutical company in China producing both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form.
 
 

Public Relations firm, primary contact:...http://ccgir.com/
Crocker Coulson
President
CCG Investor Relations
1325 Avenue of the Americas
Suite 2800
New York, NY 10019
646-213-1915 (NY office)
(323) 270 8886 (cell)
(323) 350 2793 (blackberry)
86 137 1809 5700 (china cell)
(310) 651-9658 fax
crocker.coulson@ccgir.com

 

 

 


ABOUT JIANGBO

                                                            

Jiangbo Pharmaceuticals, Inc. engages in research, development, production, marketing and sales of  pharmaceutical products in People's Republic of China ("PRC") through its operating subsidiary, Laiyang Jiangbo Pharmaceuticals Co., Ltd. ("Laiyang Jiangbo"). Jiangbo purchases patents for drugs or develops sophisticated drugs through collaboration with leading research institutions. The Company is well positioned to benefit from rapidly growing pharmaceutical market in China by its well known brand, experienced management, skilled workforce and extensive distribution network.The company is located in Northeast China in an Economic Development Zone, Laiyang City ,Shandong Province.

 

Jiangbo has 470 full time sales representatives and 620 part time representatives located in all major commerce areas across China. The company has numerous GMP (Chinese State Drug Administration or the SDA) approved manufacturing facilities and production lines,to produce various forms of Traditional Chinese Medicines and Western Medicines. The Company has a production capacity of 6 billion tablets, 70 million boxes of granules and 50 million boxes of capsules. 12 million bottles of Syrup and 8 million bottles of electuary. The acquisition of Hongrui in January 2009 increased Jiangbo' product portfolio from 6 to 28 products. The Company's best selling products include Clarithromycin sustained-release tablets, Itopride Hydrochloride granules, Baobaole Chewable Tablets, Radix Isatidis Dispersible Tablets. Currently Jiangbo has three new products in the pipeline awaiting final SFDA approval.


WEBSITES

English
http://www.jiangbopharma.com/

Chinese
http://www.jiangbo.cn/

Chinese (Translated...use the linkbottoms on the bottom , they work) :
http://translate.google.de/translate?js=y&prev=_t&hl=de&ie=UTF-8&layout=1&eotf=1&u=http%3A%2F%2Fwww.jiangbo.cn&sl=zh-CN&tl=en


 

Charts


 
 
....................................................................................................................................................................................................................................................................................................

 
....................................................................................................................................................................................................................................................................................................
 
....................................................................................................................................................................................................................................................................................................
 
Latest NEWS:
 
 

 

http://www.marketwatch.com/story/jiangbo-pharmaceuticals-signs-letter-of-intent-to-acquire-regional-wholesale-drug-distributor-in-shandong-province-2011-04-18
 
 

 
Board Info
Posts Today
0
Posts (Total)
8313
Posters
280
Moderators
New Post